Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3870563)

Published in World J Gastroenterol on December 21, 2013

Authors

Dong-Yu Li1, Hai-Bin Zhang1, Ning Yang1, Yuan Quan1, Guang-Shun Yang1

Author Affiliations

1: Dong-Yu Li, Hai-Bin Zhang, Ning Yang, Yuan Quan, Guang-Shun Yang, Fifth Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.

Articles cited by this

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology (2001) 5.12

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res (2007) 2.29

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg (2009) 1.84

Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75

Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg (2008) 1.65

Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol (2006) 1.65

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol (2009) 1.58

A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer (2001) 1.40

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. Arch Surg (2012) 1.33

The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer (1997) 1.27

Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (2000) 1.25

Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2003) 1.24

Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.20

Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2005) 1.18

The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg (2004) 1.14

Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol (2010) 1.12

Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol (2007) 1.12

Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg (2003) 1.09

Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.06

Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg (2002) 1.05

Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol (2008) 1.03

Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03

A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol (2010) 1.01

Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg (2006) 0.99

Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2005) 0.99

Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg (2002) 0.98

Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg (2010) 0.98

Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol (1999) 0.98

Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery (2009) 0.97

Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg (2001) 0.96

Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg (2009) 0.95

Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg (2010) 0.94

Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg (2008) 0.94

Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol (2007) 0.94

Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol (1999) 0.93

Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol (2010) 0.90

Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol (2010) 0.89

Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology (2005) 0.88

A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol (2006) 0.86

Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer (1998) 0.85